...
首页> 外文期刊>癌と化学療法 >A case of synchronous gastric and hepatocellular carcinoma successfully treated by TS-1 and hepatic arterial infusion chemotherapy (HAI) of low-dose CDDP
【24h】

A case of synchronous gastric and hepatocellular carcinoma successfully treated by TS-1 and hepatic arterial infusion chemotherapy (HAI) of low-dose CDDP

机译:TS-1和小剂量CDDP肝动脉灌注化疗(HAI)成功治疗同步性胃癌和肝细胞癌1例

获取原文
获取原文并翻译 | 示例

摘要

A 75-year-old man underwent distal gastrectomy for advanced gastric cancer with liver and lymph node metastases and synchronous hepatocellular carcinoma in April 2004. HAI with low-dose CDDP/TS-1 combination therapy was initiated after gastrectomy. Liver and lymph node metastases decreased significantly, with achievement of a partial response (PR) and a complete response (CR), respectively, and the hepatocellular carcinoma was reduced to 54.1% of its initial size after 3 sessions of this chemotherapy. These results suggested that combined chemotherapy with TS-1 and HAI with low-dose CDDP was not only useful for liver and lymph node metastases from gastric cancer, but for hepatocellular carcinoma as well.
机译:一名75岁的男子于2004年4月接受了远端胃切除术,以治疗晚期胃癌并伴有肝和淋巴结转移以及同步性肝细胞癌。胃切除术后开始采用低剂量CDDP / TS-1联合治疗的HAI。肝和淋巴结转移明显减少,分别实现部分缓解(PR)和完全缓解(CR),并且在3次化疗后,肝细胞癌的大小降至其初始大小的54.1%。这些结果表明,将TS-1和HAI与低剂量CDDP联合化疗不仅可用于胃癌的肝和淋巴结转移,而且还可用于肝细胞癌。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号